Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Exon 45 specific phosphorothioate oligonucleotide

EU orphan designation number: EU/3/12/991   
Active ingredient: Exon 45 specific phosphorothioate oligonucleotide
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Prosensa Therapeutics B.V.
J. H. Oortweg 21, NL-2333 CH Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/05/2012 Centralised Orphan - Designation EMA/OD/142/11 (2012)2987 of 26/04/2012